Mesa Laboratories (MLAB) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $1.30
- Estimate
- $2.55
- Surprise
- -49.1%
- Revenue (period 2026-06-30)
- $60.1M
- Score at report (before → after)
- 5.4 → 5.3/10
Revenue source: xbrl.
How the report landed
Mesa Laboratories (MLAB) missed the $2.55 estimate with diluted EPS of $1.30 — a large 49.1% shortfall. TrendMatrix's engine moved from Hold (5.4/10) to Sell at 5.3/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates MLAB Sell at 5.0/10.
3 of the last 4 quarters beat the estimate; this quarter's -49.1% surprise compares with a +9.4% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Strong earnings beat streak (3/4)
- Positive momentum
What argues against it
- Concentration risk — Product: Clinical Genomics consumables (80.0%)
- Analyst target reached - limited upside remaining
- Near 52-week high (0.1% away)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $124.76
- Price target
- $143.47
- Stop
- $116.03
- Upside to target
- +15.0%
The stock trades at 141.8× trailing but 12.1× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 71 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.
MLAB at TrendMatrix's latest read
Technology names get repriced on forward expectations more than trailing prints — a quarter here is read through next-year growth and multiple, not the EPS line alone.
- Industry
- Scientific & Technical Instruments
- Market cap
- $698.1M
- P/E (fwd)
- 12.1
- P/E (ttm)
- 141.8
- 52-week range
- $58.83–$124.89
- Off 52-week high
- 0.1%
- RSI (14)
- 71
- Volume vs avg
- 1.01×
- Score today
- 5.0/10